Aura Biosciences, Inc. announced that it will receive $80,483,829 in funding on March 17, 2021. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.16 USD | +3.02% | -4.53% | -19.19% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.19% | 344M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- AURA Stock
- News Aura Biosciences, Inc.
- Aura Biosciences, Inc. announced that it expects to receive $80.483829 million in funding